开展多国合作进行疫苗安全信号验证与假设检验的操作经验:全球疫苗安全多国合作倡议
研究测试了建立全球医院哨点网络以验证疫苗安全信号并进行假设检验的可行性。WHO所有区域的16个国家共26个哨点参与,65%来自中低收入国家。26个哨点中24个使用标准化工具成功贡献数据,研究成功确认了已知风险估计,主要挑战为病历信息不足和免疫接种数据获取困难。
要点
- 26个哨点中24个使用标准化工具成功贡献数据用于全球分析。
- 研究成功确认了目标结局的已知风险估计。
- 主要挑战为病历信息不足影响病例确认与分类,以及免疫接种数据获取困难。
核心结论
- 研究确认多国医院哨点网络用于疫苗安全监测是可行的,并证明大型国际合作研究监测中低收入国家新引入疫苗安全性的有效性和实用性。
研究设计与样本
- 研究测试了建立全球医院哨点网络用于疫苗安全信号验证和假设检验,涉及WHO所有区域的16个国家共26个哨点,其中65%来自中低收入国家。
- 26个哨点中24个使用标准化工具和程序成功贡献数据用于全球分析。
主要发现
- 研究成功确认了目标结局的已知风险估计。
- 研究者面临的主要挑战是病历中缺乏足够信息用于病例确认和分类,以及免疫接种数据获取困难。
临床怎么用
- 作者建议拟参与疫苗安全研究的哨点医院加强出院诊断编码、病历和与疫苗接种数据的链接系统。
局限性
- 研究者面临的主要挑战是病历中缺乏足够信息用于病例确认和分类,以及免疫接种数据获取困难。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Timely and effective evaluation of vaccine safety signals for newly developed vaccines introduced in low and middle- income countries (LMICs) is essential. The study tested the development of a global network of hospital-based sentinel sites for vaccine safety signal verification and hypothesis testing. Twenty-six sentinel sites in sixteen countries across all WHO regions participated, and 65% of the sites were from LMIC. We describe the process for the establishment and operationalization of such a network and the lessons learned in conducting a multi-country collaborative initiative. 24 out of the 26 sites successfully contributed data for the global analysis using standardised tools and procedures. Our study successfully confirmed the well-known risk estimates for the outcomes of interest. The main challenges faced by investigators were lack of adequate information in the medical records for case ascertainment and classification, and access to immunization data. The results suggest that sentinel hospitals intending to participate in vaccine safety studies strengthen their systems for discharge diagnosis coding, medical records and linkage to vaccination data. Our study confirms that a multi-country hospital-based network initiative for vaccine safety monitoring is feasible and demonstrates the validity and utility of large collaborative international studies to monitor the safety of new vaccines introduced in LMICs.
引用
- Guillard-Maure C, Elango V, Black S, et al. Operational lessons learned in conducting a multi-country collaboration for vaccine safety signal verification and hypothesis testing: The global vaccine safety multi country collaboration initiative. Vaccine. 2017. PMID: 28780118. doi:10.1016/j.vaccine.2017.07.085
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。